Abdominal aortic bifurcation anatomy and endograft limb size affect the use of adjunctive iliac stenting after bifurcated endograft deployment for abdominal aortic aneurysm

J Cardiovasc Surg (Torino). 2018 Apr;59(2):237-242. doi: 10.23736/S0021-9509.16.08871-6. Epub 2015 Jul 16.

Abstract

Background: The aims of the study are: 1) to define the incidence of intraoperative endograft limb stenosis >50% (ELS) after bifurcated EVAR, 2) to find risk factors for ELS considering morphology of aortic bifurcation and structural characteristics of endograft iliac limbs, and 3) to evaluate early and follow-up outcomes of intraoperative adjunctive endograft iliac stenting.

Methods: Patients treated with bifurcated EVAR for abdominal aortic aneurysm were prospectively collected from 2005 to 2011. Patient demographics, clinical risk factors, preoperative aortic bifurcation morphology (minimum and maximum diameter [ABD], calcification [ABC]), endograft iliac limb parameters (diameters [ELDs], stent material, type of endograft), ratio between ELDs and ABD), perioperative ELS and results during follow-up were analyzed. Primary outcomes were incidence of perioperative ELS and risk factors for its occurrence. Considering adjunctive stenting procedure, secondary outcomes were technical success, 30-day and mid-term iliac endograft leg patency and clinical success.

Results: Two hundred and forty-seven patients (men 233; mean age 74±7 years) were included. Mean maximum ABD was 28.9±12.9 mm. ABC was ≥50% in 56 (22.7%) cases. Median sum of ELDs was 31 mm (IQR 13-46). Endograft limb with stainless steel and nitinol stents was deployed in 69 (27.9%) and 178 (72.1%) patients. Median ELDs/ABD ratio was 1.2 (IQR: 0.9-1.5). ELS in aortic bifurcation occurred in 42 (8.5%) endograft limbs in 36 (14.6%) patients. ABD≤20 mm, ABC≥50%, ELDs≥30 mm, nitinol endograft stents and ELDs/ABD>1.4 were identified as possible positive predictive factors. At univariate and multivariate analysis, ELDs/ABD>1.4 resulted a positive prognostic factor for ELS (0.008 and 0.022, respectively). Forty-two adjunctive stents were deployed in 36 (14.6%) patients as intraoperative adjunctive procedure. Technical success, 30-day iliac endograft leg patency was 100%. Mean follow-up was 33 months (range 6-55 months) and mid-term clinical success and iliac endograft limb patency were 100%.

Conclusions: ELS is a common event after EVAR with bifurcated endograft and ELDs/ABD>1.4 results positive predictive factor. Adjunctive stenting is a safe and effective procedure and ensures optimal mid-term endograft limb patency.

Publication types

  • Observational Study

MeSH terms

  • Aged
  • Aged, 80 and over
  • Aorta, Abdominal / diagnostic imaging
  • Aorta, Abdominal / physiopathology
  • Aorta, Abdominal / surgery*
  • Aortic Aneurysm, Abdominal / diagnostic imaging
  • Aortic Aneurysm, Abdominal / physiopathology
  • Aortic Aneurysm, Abdominal / surgery*
  • Aortography
  • Blood Vessel Prosthesis Implantation / adverse effects
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Blood Vessel Prosthesis Implantation / methods
  • Blood Vessel Prosthesis*
  • Databases, Factual
  • Endovascular Procedures / adverse effects
  • Endovascular Procedures / instrumentation*
  • Endovascular Procedures / methods
  • Female
  • Graft Occlusion, Vascular / etiology
  • Graft Occlusion, Vascular / physiopathology
  • Humans
  • Iliac Artery / diagnostic imaging
  • Iliac Artery / physiopathology
  • Iliac Artery / surgery*
  • Male
  • Middle Aged
  • Prosthesis Design
  • Retrospective Studies
  • Risk Factors
  • Stents*
  • Time Factors
  • Treatment Outcome
  • Vascular Patency